ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 55 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2013 | $1,531,000 | – | 100,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 825,647 | $19,238,000 | 3.04% |
SECTORAL ASSET MANAGEMENT INC | 1,392,485 | $32,445,000 | 1.38% |
SPHERA FUNDS MANAGEMENT LTD. | 75,000 | $1,748,000 | 0.43% |
Eventide Asset Management | 52,800 | $1,230,000 | 0.17% |
Alyeska Investment Group, L.P. | 250,434 | $5,835,000 | 0.13% |
Convergence Investment Partners, LLC | 28,715 | $669,000 | 0.09% |
COLUMBUS CIRCLE INVESTORS | 253,348 | $5,903,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 66,800 | $1,557,000 | 0.04% |
Visium Asset Management, LP | 75,001 | $1,748,000 | 0.03% |
Hodges Capital Management Inc. | 15,000 | $349,000 | 0.02% |